Loading…
Reported covered position: N/A
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Supporting legislation to address cardiovascular health disparities among women [HEART for Women Act (H.R. 1014) -- all provisions]
Supporting legislation to address cardiovascular health disparities among women [HEART for Women Act (H.R. 1014) -- all provisions]
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
THERAGENICS CORPORATION via POWELL GOLDSTEIN LLP
2008 · fourth_quarter · 4T
Issues regarding Medicare reimbursement and coverage for cancer therapies
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MENTOR CORPORATION via POWELL GOLDSTEIN LLP
2008 · fourth_quarter · 4T
Source: Senate LDA
Supporting legislation to address cardiovascular health disparities among women [HEART for Women Act (H.R. 1014) -- all provisions]
Supporting legislation to address cardiovascular health disparities among women [HEART for Women Act (H.R. 1014) -- all provisions]
Comprehensive Cancer Care Improvement Act of 2007
Client: AMERICAN SOCIETY OF CLINICAL ONCOLOGY · Firm: POWELL GOLDSTEIN LLP
Issues pertaining to the federal government's regulation and coverage of cancer care and treatments (Comprehensive Cancer Care Improvement Act (H.R. 1078) -- all provisions; Legislation pertaining to Medicare average sales price (H.R. 3011) -- all provisions)
Comprehensive Cancer Care Improvement Act of 2007
Client: AMERICAN SOCIETY OF CLINICAL ONCOLOGY · Firm: POWELL GOLDSTEIN LLP
Issues pertaining to the federal government's regulation and coverage of cancer care and treatments [Comprehensive Cancer Care Improvement Act (H.R. 1078) -- all provisions; Legislation pertaining to Medicare average sales price for pharmaceuticals (H.R. 3011) -- all provisions]
Comprehensive Cancer Care Improvement Act of 2007
Client: AMERICAN SOCIETY OF CLINICAL ONCOLOGY · Firm: POWELL GOLDSTEIN LLP
Issues pertaining to the federal government's regulation and coverage of cancer care and treatments [Comprehensive Cancer Care Improvement Act (H.R. 1078) -- all provisions; Legislation pertaining to Medicare average sales price for pharmaceuticals (H.R. 3011) -- all provisions; Medicare Improvements for Patients and Providers Act (H.R. 6331) -- support provisions pertaining to physician payments]
Comprehensive Cancer Care Improvement Act of 2007
Client: AMERICAN SOCIETY OF CLINICAL ONCOLOGY · Firm: POWELL GOLDSTEIN LLP
Issues pertaining to the federal government's regulation and coverage of cancer care and treatments [Comprehensive Cancer Care Improvement Act (H.R. 1078) -- all provisions; Legislation pertaining to Medicare average sales price for pharmaceuticals (H.R. 3011) -- all provisions; Medicare Improvements for Patients and Providers Act (H.R. 6331) -- support provisions pertaining to physician payments]
FDA Scientific Fairness for Women Act
Client: MENTOR CORPORATION · Firm: POWELL GOLDSTEIN LLP
Federal regulation of medical devices, specifically breast implants (FDA Scientific Fairness for Women Act (H.R. 2503) -- all provisions)
FDA Scientific Fairness for Women Act
Client: MENTOR CORPORATION · Firm: POWELL GOLDSTEIN LLP
Federal regulation of medical devices, specifically breast implants [FDA Scientific Fairness for Women Act (H.R. 2503) -- all provisions]
FDA Scientific Fairness for Women Act
Client: MENTOR CORPORATION · Firm: POWELL GOLDSTEIN LLP
Federal regulation of medical devices, specifically breast implants [FDA Scientific Fairness for Women Act (H.R. 2503) -- all provisions]
FDA Scientific Fairness for Women Act
Client: MENTOR CORPORATION · Firm: POWELL GOLDSTEIN LLP
Federal regulation of medical devices, specifically breast implants [FDA Scientific Fairness for Women Act (H.R. 2503) -- all provisions]
To amend title XVIII of the Social Security Act to ensure adequate payment amounts for drugs and biologicals under part B of the Medicare Program.
Client: AMERICAN SOCIETY OF CLINICAL ONCOLOGY · Firm: POWELL GOLDSTEIN LLP
Issues pertaining to the federal government's regulation and coverage of cancer care and treatments (Comprehensive Cancer Care Improvement Act (H.R. 1078) -- all provisions; Legislation pertaining to Medicare average sales price (H.R. 3011) -- all provisions)
To amend title XVIII of the Social Security Act to ensure adequate payment amounts for drugs and biologicals under part B of the Medicare Program.
Client: AMERICAN SOCIETY OF CLINICAL ONCOLOGY · Firm: POWELL GOLDSTEIN LLP
Issues pertaining to the federal government's regulation and coverage of cancer care and treatments [Comprehensive Cancer Care Improvement Act (H.R. 1078) -- all provisions; Legislation pertaining to Medicare average sales price for pharmaceuticals (H.R. 3011) -- all provisions]
To amend title XVIII of the Social Security Act to ensure adequate payment amounts for drugs and biologicals under part B of the Medicare Program.
Client: AMERICAN SOCIETY OF CLINICAL ONCOLOGY · Firm: POWELL GOLDSTEIN LLP
Issues pertaining to the federal government's regulation and coverage of cancer care and treatments [Comprehensive Cancer Care Improvement Act (H.R. 1078) -- all provisions; Legislation pertaining to Medicare average sales price for pharmaceuticals (H.R. 3011) -- all provisions; Medicare Improvements for Patients and Providers Act (H.R. 6331) -- support provisions pertaining to physician payments]
To amend title XVIII of the Social Security Act to ensure adequate payment amounts for drugs and biologicals under part B of the Medicare Program.
Client: AMERICAN SOCIETY OF CLINICAL ONCOLOGY · Firm: POWELL GOLDSTEIN LLP
Issues pertaining to the federal government's regulation and coverage of cancer care and treatments [Comprehensive Cancer Care Improvement Act (H.R. 1078) -- all provisions; Legislation pertaining to Medicare average sales price for pharmaceuticals (H.R. 3011) -- all provisions; Medicare Improvements for Patients and Providers Act (H.R. 6331) -- support provisions pertaining to physician payments]
Medicare Improvements for Patients and Providers Act of 2008
Client: THERAGENICS CORPORATION · Firm: POWELL GOLDSTEIN LLP
Issues regarding Medicare reimbursement and coverage for cancer therapies [Medicare Improvements for Patients and Providers Act (H.R. 6331) -- provision pertaining to brachytherapy]
Medicare Improvements for Patients and Providers Act of 2008
Client: AMERICAN SOCIETY OF CLINICAL ONCOLOGY · Firm: POWELL GOLDSTEIN LLP
Issues pertaining to the federal government's regulation and coverage of cancer care and treatments [Comprehensive Cancer Care Improvement Act (H.R. 1078) -- all provisions; Legislation pertaining to Medicare average sales price for pharmaceuticals (H.R. 3011) -- all provisions; Medicare Improvements for Patients and Providers Act (H.R. 6331) -- support provisions pertaining to physician payments]
Medicare Improvements for Patients and Providers Act of 2008
Client: AMERICAN SOCIETY OF CLINICAL ONCOLOGY · Firm: POWELL GOLDSTEIN LLP
Issues pertaining to the federal government's regulation and coverage of cancer care and treatments [Comprehensive Cancer Care Improvement Act (H.R. 1078) -- all provisions; Legislation pertaining to Medicare average sales price for pharmaceuticals (H.R. 3011) -- all provisions; Medicare Improvements for Patients and Providers Act (H.R. 6331) -- support provisions pertaining to physician payments]
Medicare Improvements for Patients and Providers Act of 2008
Client: THERAGENICS CORPORATION · Firm: POWELL GOLDSTEIN LLP
Issues regarding Medicare reimbursement and coverage for cancer therapies [Medicare Improvements for Patients and Providers Act (H.R. 6331) -- provision pertaining to brachytherapy]
To amend the War Powers Resolution to require the President to include post-conflict strategy in the report required under the Resolution, and for other purposes.
Client: A LA MODE, INC. · Firm: POWELL GOLDSTEIN LLP
Support consumer protections, including efforts to preserve the independence and quality of appraisals in the mortgage lending process [Foreclosure Prevention Act (H.R. 3221) -- provisions pertaining to appraisals]
To amend the War Powers Resolution to require the President to include post-conflict strategy in the report required under the Resolution, and for other purposes.
Client: A LA MODE, INC. · Firm: POWELL GOLDSTEIN LLP
Support efforts to preserve the independence and quality of appraisals in the mortgage lending process [Foreclosure Prevention Act (H.R. 3221) -- provisions pertaining to appraisals]
Comprehensive Cancer Care Improvement Act of 2007
Client: AMERICAN SOCIETY OF CLINICAL ONCOLOGY · Firm: POWELL GOLDSTEIN LLP
Issues pertaining to the federal government's regulation and coverage of cancer care and treatments (H.R. 3011 and H.R. 1078) -- all provisions
FDA Scientific Fairness for Women Act
Client: MENTOR CORPORATION · Firm: POWELL GOLDSTEIN LLP
Monitor Congressional and regulatory processes as they would affect medical devices, specifically breast implants (H.R. 2503)
To amend title XVIII of the Social Security Act to ensure adequate payment amounts for drugs and biologicals under part B of the Medicare Program.
Client: AMERICAN SOCIETY OF CLINICAL ONCOLOGY · Firm: POWELL GOLDSTEIN LLP
Issues pertaining to the federal government's regulation and coverage of cancer care and treatments (H.R. 3011 and H.R. 1078) -- all provisions
Federal regulation of medical devices, specifically breast implants [FDA Scientific Fairness for Women Act (H.R. 2503) -- all provisions]
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
AMERICAN SOCIETY OF CLINICAL ONCOLOGY via POWELL GOLDSTEIN LLP
2008 · fourth_quarter · 4T
Issues related to the quality of cancer care
Issues pertaining to the federal government's regulation and coverage of cancer care and treatments [Comprehensive Cancer Care Improvement Act (H.R. 1078) -- all provisions; Legislation pertaining to Medicare average sales price for pharmaceuticals (H.R. 3011) -- all provisions]
Increase funding for National Institutes of Health programs as they pertain to cancer research
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMOENA USA CORPORATION via POWELL GOLDSTEIN LLP
2008 · fourth_quarter · 4T
Medicare coverage issues pertaining to post-surgical mastectomy products
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN HEART ASSOCIATION via POWELL GOLDSTEIN LLP
2008 · fourth_quarter · 4T
Supporting legislation to address cardiovascular health disparities among women
Filing targets: HOUSE OF REPRESENTATIVES
A LA MODE, INC. via POWELL GOLDSTEIN LLP
2008 · fourth_quarter · 4T
Support efforts to preserve the independence and quality of appraisals in the mortgage lending process
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
THERAGENICS CORPORATION via POWELL GOLDSTEIN LLP
2008 · third_quarter · Q3
Issues regarding Medicare reimbursement and coverage for cancer therapies [Medicare Improvements for Patients and Providers Act (H.R. 6331) -- provision pertaining to brachytherapy]
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MENTOR CORPORATION via POWELL GOLDSTEIN LLP
2008 · third_quarter · Q3
Federal regulation of medical devices, specifically breast implants [FDA Scientific Fairness for Women Act (H.R. 2503) -- all provisions]
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
AMERICAN SOCIETY OF CLINICAL ONCOLOGY via POWELL GOLDSTEIN LLP
2008 · third_quarter · Q3
Issues pertaining to the federal government's regulation and coverage of cancer care and treatments [Comprehensive Cancer Care Improvement Act (H.R. 1078) -- all provisions; Legislation pertaining to Medicare average sales price for pharmaceuticals (H.R. 3011) -- all provisions; Medicare Improvements for Patients and Providers Act (H.R. 6331) -- support provisions pertaining to physician payments]
Issues related to the quality of cancer care
Increase funding for National Institutes of Health programs as they pertain to cancer research
AMOENA USA CORPORATION via POWELL GOLDSTEIN LLP
2008 · third_quarter · Q3
Medicare coverage issues pertaining to post-surgical mastectomy products
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICAN HEART ASSOCIATION via POWELL GOLDSTEIN LLP
2008 · third_quarter · Q3
Supporting legislation to address cardiovascular health disparities among women [HEART for Women Act (H.R. 1014) -- all provisions]
Filing targets: HOUSE OF REPRESENTATIVES
A LA MODE, INC. via POWELL GOLDSTEIN LLP
2008 · third_quarter · Q3
Support efforts to preserve the independence and quality of appraisals in the mortgage lending process [Foreclosure Prevention Act (H.R. 3221) -- provisions pertaining to appraisals]
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
AMOENA USA CORPORATION via POWELL GOLDSTEIN LLP
2008 · third_quarter · RR
Medicare coverage issues pertaining to post-surgical mastectomy products
Medicare coverage issues pertaining to post-surgical mastectomy products
THERAGENICS CORPORATION via POWELL GOLDSTEIN LLP
2008 · second_quarter · Q2
Issues regarding Medicare reimbursement and coverage for cancer therapies [Medicare Improvements for Patients and Providers Act (H.R. 6331) -- provision pertaining to brachytherapy]
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MENTOR CORPORATION via POWELL GOLDSTEIN LLP
2008 · second_quarter · Q2
Federal regulation of medical devices, specifically breast implants [FDA Scientific Fairness for Women Act (H.R. 2503) -- all provisions]
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
AMERICAN HEART ASSOCIATION via POWELL GOLDSTEIN LLP
2008 · second_quarter · Q2
Supporting legislation to address cardiovascular health disparities among women [HEART for Women Act (H.R. 1014) -- all provisions]
Filing targets: HOUSE OF REPRESENTATIVES
AMERICAN HEART ASSOCIATION via POWELL GOLDSTEIN LLP
2008 · second_quarter · RA
Supporting legislation to address cardiovascular health disparities among women [HEART for Women Act (H.R. 1014) -- all provisions]
AMERICAN SOCIETY OF CLINICAL ONCOLOGY via POWELL GOLDSTEIN LLP
2008 · second_quarter · Q2
Increase funding for National Institutes of Health programs as they pertain to cancer research
Issues pertaining to the federal government's regulation and coverage of cancer care and treatments [Comprehensive Cancer Care Improvement Act (H.R. 1078) -- all provisions; Legislation pertaining to Medicare average sales price for pharmaceuticals (H.R. 3011) -- all provisions; Medicare Improvements for Patients and Providers Act (H.R. 6331) -- support provisions pertaining to physician payments]
Issues related to the quality of cancer care
A LA MODE, INC. via POWELL GOLDSTEIN LLP
2008 · second_quarter · Q2
Support consumer protections, including efforts to preserve the independence and quality of appraisals in the mortgage lending process [Foreclosure Prevention Act (H.R. 3221) -- provisions pertaining to appraisals]
Filing targets: HOUSE OF REPRESENTATIVES, SENATE, Treasury, Dept of
AMERICAN HEART ASSOCIATION via POWELL GOLDSTEIN LLP
2008 · second_quarter · RR
Supporting legislation to address cardiovascular health disparities among women [HEART for Women Act (H.R. 1014) -- all provisions]
A LA MODE, INC. via POWELL GOLDSTEIN LLP
2008 · second_quarter · RR
Support consumer protections, including the need for independent appraisals, in the mortgage lending and home selling processes
Support consumer protections, including the need for independent appraisals, in the mortgage lending and home selling processes
THERAGENICS CORPORATION via POWELL GOLDSTEIN LLP
2008 · first_quarter · Q1
Issues regarding Medicare reimbursement and coverage for cancer therapies
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MENTOR CORPORATION via POWELL GOLDSTEIN LLP
2008 · first_quarter · Q1
Federal regulation of medical devices, specifically breast implants (FDA Scientific Fairness for Women Act (H.R. 2503) -- all provisions)
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
AMERICAN SOCIETY OF CLINICAL ONCOLOGY via POWELL GOLDSTEIN LLP
2008 · first_quarter · Q1
Issues pertaining to the federal government's regulation and coverage of cancer care and treatments (Comprehensive Cancer Care Improvement Act (H.R. 1078) -- all provisions; Legislation pertaining to Medicare average sales price (H.R. 3011) -- all provisions)
Issues related to the quality of cancer care
Increase funding for National Institutes of Health programs as they pertain to cancer research
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
MENTOR CORPORATION via POWELL GOLDSTEIN LLP
2007 · year_end · YY
Monitor Congressional and regulatory processes as they would affect medical devices, specifically breast implants (H.R. 2503)
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
AMERICAN SOCIETY OF CLINICAL ONCOLOGY via POWELL GOLDSTEIN LLP
2007 · year_end · YY
Issues related to the quality of cancer care
Funding issues regarding the National Institutes of Health as they pertain to cancer research
Issues pertaining to the federal government's regulation and coverage of cancer care and treatments (H.R. 3011 and H.R. 1078) -- all provisions
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AMERICAN SOCIETY OF CLINICAL ONCOLOGY via POWELL GOLDSTEIN LLP
2007 · year_end · RR
Issues pertaining to the federal government's regulation and coverage of cancer care and treatments. Issues related to the quality of cancer care. Funding issues regarding the National Institutes of Health as they pertain to cancer research.
Issues pertaining to the federal government's regulation and coverage of cancer care and treatments. Issues related to the quality of cancer care. Funding issues regarding the National Institutes of Health as they pertain to cancer research.
Issues pertaining to the federal government's regulation and coverage of cancer care and treatments. Issues related to the quality of cancer care. Funding issues regarding the National Institutes of Health as they pertain to cancer research.
MENTOR CORPORATION via POWELL GOLDSTEIN LLP
2007 · year_end · RR
Monitor Congressional and regulatory processes as they would affect medical devices, specifically breast implants.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE